cancer-treatment

Documents about cancer-treatment

• Optimizing breast cancer treatment strategies through fractional-order dynamics: A computational modeling approach.#189948NCBI PubMed Central
• Nanotechnology in Cancer Therapy: How Nanoparticles Are Shaping the Future of Personalized Treatment.#199141NCBI PubMed Central
• Child and Adolescent Cancer Communication Preferences for Treatment Decision Making: A Meta-Synthesis.#219048NCBI PubMed Central
• A pan-cancer, pan-treatment model for predicting drug responses from patient-derived xenografts#222001Spiral
• A review of application of Artificial Intelligence in breast cancer detection and treatment.#242263NCBI PubMed Central
• NeoMET Study in Neoadjuvant Treatment of Breast Cancer#252958ClinicalTrials.gov
• Neoadjuvant Treatment in Upper Rectal Cancer Does Not Improve Oncologic Outcomes But Increases Postoperative Morbidity#311887HAL (France)
• Machine learning applications in predicting pharmacological treatment outcomes and responses in esophageal cancer.#334758NCBI PubMed Central
• Metabolomics in breast cancer: insights into treatment responses, disease progression, and prognostic assessment.#342459NCBI PubMed Central
• Cemiplimab as Maintenance Treatment for Advanced Adrenocortical Cancer#346930ClinicalTrials.gov
• Personalized Therapy and Liquid Biopsy-A Focus on Colorectal Cancer#364058HAL (France)
• Regional Inequities In Colon Cancer Surgical Care: Treatment Delay Patterns Across U.s. Facilities#369367EliScholar
• A machine learning approach to profiling anxiety risk among cancer patients on treatment.#382589NCBI PubMed Central
• Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma#448257ClinicalTrials.gov
• Evaluation of Cytokine-induced Killer (CIK) Cells as Therapy or Adjuvant Treatment for Advanced HCC#454011ClinicalTrials.gov
• Evaluating surrogates for overall survival in the adjuvant treatment of bladder cancer with chemotherapy#465508PubMed Central
• Psychophysiological changes during breast cancer treatment: a longitudinal analysis of subjective and objective indicators.#670948NCBI PubMed Central
• Homeopathic Treatment of Fatigue in Children Receiving Chemotherapy#800276ClinicalTrials.gov
• Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC#805227ClinicalTrials.gov
• Radiation therapy management in BRCA1/2 carriers diagnosed with early breast cancer: An international cohort study#15438HAL (France)
• Testing an Anti-cancer Radio-Active Immunotherapy Called Lintuzumab Ac225 in Patients With High-Risk Myelodysplastic Syndrome That Has Not Responded to Other Treatment#123443ClinicalTrials.gov
• Assessment of the Safety and Efficacy of Balstilimab in Combination With Botensilimab for the Treatment of Non-Small Cell Lung Cancer (IMMONC0008)#181773ClinicalTrials.gov
• Optimized exercise prescription for alleviating cancer-related fatigue in breast cancer survivors after primary treatment: a systematic review and dose-response network meta-analysis.#247447NCBI PubMed Central
• Immunotherapy Using Pluripotent Killer-Human Epidermal Growth Factor Receptor-2 (PIK-HER2) Cells for the Treatment of Advanced Gastric Cancer With Liver Metastasis#253004ClinicalTrials.gov
• An Investigational Immunotherapy Study of Nivolumab With Standard of Care Therapy vs Standard of Care Therapy for First-Line Treatment of Colorectal Cancer That Has Spread#261509ClinicalTrials.gov
• Leveraging the bacteria for enhanced cancer immunotherapy: from a perspective of synthetic biology#266487Europe PMC
• Plant-derived modulators of tumor metabolism as novel, efficacious, and low-toxicity therapeutic agents for cancer treatment#278372University of Pretoria Repository
• Ringworm and Irradiation#343938DOAB PROD Instance
• WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention#390527WHO IRIS
• PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment#435751ClinicalTrials.gov
• HIV-protease inhibitors for the treatment of cancer: Repositioning HIV protease inhibitors while developing more potent NO-hybridized derivatives?#643943IBISS
• The waiting time paradox: population based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland#652662Enlighten Publications
• An Internet-based Psychosexual Intervention for Couples Following Treatment for Breast Cancer#805917ClinicalTrials.gov
• This Study Aims to Optimize Neoadjuvant Therapy for HER2-positive Breast Cancer by Implementing a Dynamic Monitoring-guided Treatment Strategy.#807342ClinicalTrials.gov
• NKG2D/CLDN18.2 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumors#810456ClinicalTrials.gov
• Predictors of Acute Toxicity and Flap Failure After Adjuvant Treatment for Locally Advanced Head and Neck Cancer#810598ClinicalTrials.gov
• Expert recommendations on treatment sequencing and challenging clinical scenarios in human epidermal growth factor receptor 2-positive (HER2-positive) metastatic breast cancer#239272IRIS
• How effective is the CA 19.9 tumor marker in monitoring treatment response in patients with gastrointestinal cancers?#177360Zenodo
• Effect of osteopathic manipulative treatment on pain in palliative care patients: a randomized placebo-controlled clinical trial#340086HAL (France)
• Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial#804069ClinicalTrials.gov
• Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)#290969ClinicalTrials.gov
• Ethical and legal concerns in artificial intelligence applications for the diagnosis and treatment of lung cancer: a scoping review#19915DOAJ
• DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer#28306ClinicalTrials.gov
• PD-1 Knockout Anti-MUC1 CAR-T Cells in the Treatment of Advanced Breast Cancer#140987ClinicalTrials.gov
• Durvalumab (MEDI4736) and Radiosurgery (fSRT Vs. PULSAR) for the Treatment of Non-Small Cell Lung Cancer Brain Metastases#154655ClinicalTrials.gov
• Efficacy and Safety of FOLFOX+Cetuximab vs. FOLFOXIRI+Bevacizumab Both With QL1706 in First-Line Treatment of Left-Sided mCRC#230417ClinicalTrials.gov
• Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer#287563ClinicalTrials.gov
• XELOX +Bev +Tislelizumab for First-line Treatment of MSS/pMMR RAS-mutated mCRC#311133ClinicalTrials.gov
• The BEVATOMOX phase II trial: raltitrexed/oxaliplatin/bevacizumab vs mFOLFOX6/bevacizumab in 2nd-line metastatic colorectal cancer#311896HAL (France)
• Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer#314329ClinicalTrials.gov